Biotech · Public company · Newton, MA, US

Acumen Pharmaceuticals, Inc.

Ticker ABOS · SEC CIK 0001576885

Track this companyFree. Adds Acumen Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials31 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline4

sabirnetugPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
ACU193Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
sabirnetug (ACU193)Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Sabirnetug + rHuPH20Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026

A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy ParticipantsPHASE1 · COMPLETED · started Jun 25, 2024ClinicalTrials.gov NCT06511570 · fetched Nov 12, 2026
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 29, 2024ClinicalTrials.gov NCT06335173 · fetched Nov 12, 2026
A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild ADPHASE1 · COMPLETED · started Jun 21, 2021ClinicalTrials.gov NCT04931459 · fetched Nov 12, 2026